I was diagnosed in 2017 at 59 years old with stage 4 Gleason 9 disease with bone mets, plus a lung met, and my PSA was only 11 at diagnosis. This gradually dropped to a nadir of 0.15 in October 2019, but since then, it's been three successive increases - 0.16 in November, 0.19 in January and now 0.32 in July.
I had a 6 monthly Oncology appointment by telephone today, and she was happy with this low psa of 0.32.
It was an average of 0.175 throughout last year. She said that moving onto Bicalutamide is only when above 2, but maybe 1 in my case.
I asked her about the "20% increase over two successive tests of at least a week apart" etc. types of criteria, but she just said it would have to be over 1, and there's no benefit in taking Bicalutamide earlier.
So this doc seemed happy enough, she will test again in three or six months, but we are a bit confused by these increases which seem significant percentagewise, and so I would appreciate any thoughts please.
Thank you all very much.
Michael